Weingrill, Eva <br/><br/>
Roscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients' pretreatment status.  [electronic resource] 

 -  Haematologica  Sep 2007 
 - 1286-8 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.10680  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alemtuzumab<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--administration & dosage<br/>Antigens, CD--metabolism<br/>Antigens, Neoplasm--metabolism<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Apoptosis--drug effects<br/>CD52 Antigen<br/>Cohort Studies<br/>Drug Synergism<br/>Female<br/>Glycoproteins--metabolism<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Male<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Purines--administration & dosage<br/>Roscovitine<br/>Salvage Therapy